Skip to content
value.today
Sensus Healthcare, LLC logo

Sensus Healthcare, LLC

🇺🇸 Boca Raton, Florida, USAHealth CareFounded 2010
Total raised
$6 M
3 rounds on record
Latest round
$2 M
Dec 2015
First round on record
Mar 2012
Today
Went public
See the company page

Sensus Healthcare, LLC is listed today as Sensus Healthcare, Inc.: market value, financials and filings are on its company page.

Funding rounds

3 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Sensus Healthcare, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2015$2 MNo. 3$2 to $10 million

Sensus Healthcare, LLC: Raise no. 3, Dec 2015

Investors in this round

58 investors had bought by the notice of Jan 5, 2016: 58 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$25,000
What was sold
equity, other: The securities sold in this offering were limited liability company membership units of Sensus Healthcare, LLC, which subsequently converted into shares of common stock of Sensus Healthcare, Inc. in c
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$154,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Arthur C. Levine · Executive Officer · Chief Financial Officer
  • Joseph C. Sardano · Executive Officer, Director · Chief Executive Officer
  • Kalman C. Fishman · Executive Officer · Chief Technology Officer and Chief Operating Officer
  • John C. Heinrich · Director
  • Samuel C. O'Rear · Director
  • William C. McCall · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Neidiger, Tucker, Bruner, Inc. (CRD 7425) · Englewood, ColoradoSold in AZ, CA, CO, DC, IL, KS, ME, MN, NH, NJ, SD, TX, VA

Remarks in the notice

  • On fees: “Pursuant to the placement agency agreement, the placement agent received commissions equal to 6.5% of the gross proceeds of the offering plus a non-accountable expense reimbursement of 0.5% of the gross proceeds of the offering.”

Signed by Joseph C. Sardano, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 5, 2016. Read the notice at the SEC.

equitySEC
Jan 2013$1 MNo. 2Under $2 million

Sensus Healthcare, LLC: Raise no. 2, Jan 2013

Investors in this round

25 investors had bought by the notice of Jan 18, 2013: 25 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $4 M offered; $2 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$27,000
Finders' fees
none
Paid to its own people
$100,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joseph C. Sardano · Executive Officer, Director
  • Kal C. Fishman · Executive Officer
  • Richard C. Golin · Executive Officer
  • Stephen C. Arnold · Executive Officer
  • Steve C. Cohen · Executive Officer
  • Don C. Stansberry · Director
  • John C. Heinrich · Director
  • Mark C. Cherney · Director
  • Sam C. O'Rear · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • NEIDIGER, TUCKER, BRUNER, INC. (CRD 7425) · broker-dealer NEIDIGER, TUCKER, BRUNER, INC. (CRD 7425) · Englewood, ColoradoSold in CA, CO, IL, KS, MN, MT, NJ, NM, NY, SD, TX, WI

Remarks in the notice

  • On fees: “The Placement Agent will receive (i) cash equal to 7.5% of gross proceeds raised in the Offering, (ii) warrants to purchase 10% of the total number of Interests sold in the Offering and (iii) a 1% non-accountable expense not less than $15,000.”

Signed by Joseph C. Sardano, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Jan 18, 2013. Read the notice at the SEC.

equitySEC
Mar 2012$2 MNo. 1$2 to $10 million

Sensus Healthcare, LLC: Raise no. 1, Mar 2012

Investors in this round

19 investors had bought by the notice of Dec 19, 2012: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $6 M offered; $4 M still to sell
Smallest investment taken
$15,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$178,875
Finders' fees
none
Paid to its own people
$27,000 (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Joseph C. Sardano · Executive Officer, Director
  • Kal C. Fishman · Executive Officer
  • Richard C. Golin · Executive Officer
  • Stephen C. Arnold · Executive Officer
  • Steve C. Cohen · Executive Officer
  • Don C. Stansberry · Director
  • John C. Heinrich · Director
  • Mark C. Cherney · Director
  • Sam C. O'Rear · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • STERNE, AGEE & LEACH, INC. (CRD 791) · broker-dealer STERNE, AGEE & LEACH, INC. (CRD 791) · Birmingham, AlabamaSold in AL, AZ, FL, LA, TN, VA

Remarks in the notice

  • On the amounts: “The issuer closed the offering and no more securities will be sold.”

Signed by Joseph C. Sardano, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Dec 19, 2012. Read the notice at the SEC.

equitySEC
Jun 2010$6 MIssued in a merger or acquisition$2 to $10 million

Sensus Healthcare, LLC: Private sale, Jun 2010

Investors in this round

37 investors had bought by the notice of Mar 29, 2011: 37 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $7 M offered; $1 M still to sell
Smallest investment taken
$25,000
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$420,000
Finders' fees
none
Paid to its own people
$1,287,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Armand C. Cognetta, Jr. · Executive Officer
  • Joseph C. Sardano · Executive Officer, Director
  • Kalman C. Fishman · Executive Officer
  • Richard C. Golin · Executive Officer
  • Stephen C. Cohen · Executive Officer
  • John C. Heinrich · Director · Prospective Board member to be appointed upon close of offering.
  • Mark G. Cherney · Director · Prospective Board member to be appointed upon close of offering.
  • Samuel C. O'Rear · Director · Prospective Board member to be appointed upon close of offering.

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Anderson & Strudwick, Incorporated (CRD 48) · Richmond, VirginiaSold in all US states

Remarks in the notice

  • On fees: “Anderson & Strudwick, Incorporated, as placement agent, will receive a 6% membership interest in the Company as well as 6% of the gross proceeds raised in the offering. $420,000 is 6% of $7,000,000, the maximum offering amount.”
  • On the amounts: “Maximum offering is $7,000,000 but Company may close offering at any time once $1,500,000 is received.”
  • On the use of proceeds: “If $7,000,000 is raised, payments of salaries and benefits to executive officers and directors will be approximately $1,287,000. If the offering is closed after $1,500,000 is raised, such salaries and benefits would be approximately $858,000.”

Signed by Stephen G. Arnold, Cfo. Source: SEC Form D and 1 amendment, newest notice filed Mar 29, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • As the listed company Sensus Healthcare, Inc., its revenue in fiscal 2025 came from these product and service lines: Service Revenue $3.46 million (13%), Product Revenue $1.72 million (6%).

    Annual report (SEC XBRL) · Dec 2025

  • Sensus Healthcare, LLC chose not to state its revenue in its newest notice of a funding round (Jan 2016).

    SEC Form D · Jan 2016

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jan 2016

Products and services#

No products or services of Sensus Healthcare, LLC are on record.

Investors#

No investor of Sensus Healthcare, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 58 investors.

Largest shareholders today

Institutions holding Sensus Healthcare, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Sensus Healthcare, LLC
NameRoleNamed in
Arthur C. LevineChief Financial OfficerJan 2016
Joseph C. SardanoChief Executive OfficerJan 2016
Kalman C. FishmanChief Technology Officer and Chief Operating OfficerJan 2016
Kal C. FishmanExecutive officerJan 2013
Richard C. GolinExecutive officerJan 2013
Stephen C. ArnoldExecutive officerJan 2013
Steve C. CohenExecutive officerJan 2013
Armand C. Cognetta, Jr.Executive officerMar 2011
Stephen C. CohenExecutive officerMar 2011
John C. HeinrichDirectorJan 2016
Joseph C. SardanoChief Executive OfficerJan 2016
Samuel C. O'RearDirectorJan 2016
William C. McCallDirectorJan 2016
Don C. StansberryDirectorJan 2013
Mark C. CherneyDirectorJan 2013
Sam C. O'RearDirectorJan 2013
Mark G. CherneyProspective Board member to be appointed upon close of offering.Mar 2011

Went public since 2016. Its SEC number is that of a company listed on a stock exchange.